Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J'xactly study

被引:2
|
作者
Migita, Shohei [1 ]
Okumura, Yasuo [1 ]
Fukuda, Ikuo [2 ]
Nakamura, Mashio [3 ]
Yamada, Norikazu [4 ]
Takayama, Morimasa [5 ]
Maeda, Hideaki [6 ]
Yamashita, Takeshi [7 ]
Ikeda, Takanori [8 ]
Mo, Makoto [9 ]
Yamazaki, Tsutomu [10 ]
Hirayama, Atsushi [11 ]
机构
[1] Nihon Univ, Dept Med, Div Cardiol, Sch Med, Tokyo, Japan
[2] Keimeikai Yokawa Hosp, Dept Cardiol, Miki, Japan
[3] Nakamura Med Clin, Kuwana, Japan
[4] Kuwana City Med Ctr, Dept Cardiol, Kuwana, Japan
[5] Sakakibara Heart Inst, Dept Cardiol, Fuchu, Japan
[6] Ukima Cent Hosp, Vasc Ctr, Dept Heart, Tokyo, Japan
[7] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo, Japan
[8] Toho Univ, Dept Cardiovasc Med, Fac Med, Tokyo, Japan
[9] Yokohama Minami Kyosai Hosp, Dept Cardiovasc Surg, Yokohama, Japan
[10] Int Univ Hlth & Welf, Innovat & Res Support Ctr, Tokyo, Japan
[11] Osaka Police Hosp, Dept Cardiol, Osaka, Japan
来源
关键词
anticoagulant; bleeding; recurrence; rivaroxaban; venous thromboembolism; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ATRIAL-FIBRILLATION; MAJOR CONTRIBUTOR; MARKERS;
D O I
10.3389/fcvm.2023.1074661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: D-dimer is a biomarker of fibrin production and degradation, and changes in D-dimer concentration suggest fibrin clot formation, which is associated with thromboembolism and hypercoagulable states. Thus, an elevated D-dimer concentration could be a useful prognostic predictor for patients with venous thromboembolism (VTE).Methods and results: In this subanalysis of the J'xactly study, a prospective multicenter study conducted in Japan, we examined the clinical outcomes of 949 patients with VTE stratified by baseline D-dimer concentration. The median D-dimer concentration was 7.6 mu g/ml (low D-dimer group: n = 473, 49.8%]; high D-dimer group:>= 7.6 mu g/ml [n = 476, 50.2%]). The mean age of the patients was 68 years, and 386 patients (40.7%) were male. Compared with the low D-dimer group, the high D-dimer group had more frequent pulmonary embolism with or without deep vein thrombosis (DVT), proximal DVT, atrial fibrillation, or diabetes mellitus, and underwent intensive treatment with 30 mg/day rivaroxaban. The incidence of composite clinically relevant events (recurrence or exacerbation of symptomatic VTE, acute coronary syndrome [ACS], ischemic stroke, death from any cause, or major bleeding) was higher in the high D-dimer group than in the low D-dimer group (11.1% vs. 7.5% per patient-year; hazard ratio, 1.46; 95% confidence interval, 1.05-2.04; p = 0.025). There was no significant difference between the high and low D-dimer groups in the incidence of VTE (2.8% vs. 2.5% per patient-year, respectively; p = 0.788), ACS (0.4% per patient-year vs. not observed, respectively; p = 0.078), or major bleeding (4.0% vs. 2.1% per patient-year, respectively; p = 0.087), but there was a significant difference in the incidence of ischemic stroke (1.0% per patient-year vs. not observed, respectively; p = 0.004).Conclusion: Elevated D-dimer concentration may be an important prognostic predictor in Japanese patients with VTE.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism ― Subanalysis of the J'xactly Study ―
    Nakamura, Mashio
    Fukuda, Ikuo
    Yamada, Norikazu
    Takayama, Morimasa
    Maeda, Hideaki
    Yamashita, Takeshi
    Ikeda, Takanori
    Mo, Makoto
    Yamazaki, Tsutomu
    Okumura, Yasuo
    Hirayama, Atsushi
    CIRCULATION REPORTS, 2023, 5 (04) : 144 - 151
  • [22] Rapid ELISA D-dimer testing in the exclusion of venous thromboembolism in hospitalized patients
    Freyburger, G
    Trillaud, H
    Labrouche, S
    Gauthier, P
    Javorschi, S
    Grenier, N
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2000, 6 (02) : 77 - 81
  • [23] The factors associated with elevated D-dimer level in patients with acute venous thromboembolism
    Vorobyeva, N.
    Dobrovolsky, A.
    Titaeva, E.
    Ermolina, O.
    Balakhonova, T.
    Kirienko, A.
    Panchenko, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 334 - 334
  • [24] D-Dimer Improves Risk Prediction of Venous Thromboembolism in Patients with Multiple Myeloma
    Sanfilippo, Kristen M.
    Fiala, Mark A.
    Tathireddy, Harsha
    Feinberg, Dan
    Vij, Ravi
    Gage, Brian F.
    BLOOD, 2020, 136
  • [25] Impact of D-dimer for Prediction of Occult Cancer in Patients With Unprovoked Venous Thromboembolism
    Han, Donghee
    Cho, In-Jeong
    Shim, Chi Young
    Chang, Hyuk-Jae
    Hong, Geu-Ru
    Ha, Jong-Won
    Chung, Namsik
    CIRCULATION, 2015, 132
  • [26] D-dimer testing in elderly patients in primary care for exclusion of venous thromboembolism
    Siccama, R. N.
    Janssen, K. J. M.
    Oudega, R.
    Van Delden, J. J. M.
    Moons, K. G. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) : 1972 - 1973
  • [27] Diagnostic Value of D-Dimer for Venous Thromboembolism in Korean Patients with a Brain Lesion
    Park, Geun-Young
    Im, Sun
    Kim, Yeon Jin
    CEREBROVASCULAR DISEASES, 2014, 38 : 50 - 50
  • [28] D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer
    Kodama, J.
    Seki, N.
    Masahiro, S.
    Kusumoto, T.
    Nakamura, K.
    Hongo, A.
    Hiramatsu, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1651 - 1656
  • [29] Efficacy of D-Dimer Assay in Pulmonary Venous Thromboembolism: Study of 76 Cases
    Saxena, Shubhi
    Saxena, Nishant
    Jain, Richa
    Jasani, Jasmin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (02) : CP7 - CP7
  • [30] D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan ― From the CLOT-COVID Study ―
    Ikeda, Nobutaka
    Yachi, Sen
    Takeyama, Makoto
    Nishimoto, Yuji
    Tsujino, Ichizo
    Nakamura, Junichi
    Yamamoto, Naoto
    Nakata, Hiroko
    Ikeda, Satoshi
    Umetsu, Michihisa
    Aikawa, Shizu
    Hayashi, Hiroya
    Satokawa, Hirono
    Okuno, Yoshinori
    Iwata, Eriko
    Ogihara, Yoshito
    Kondo, Akane
    Iwai, Takehisa
    Yamada, Norikazu
    Ogawa, Tomohiro
    Kobayashi, Takao
    Mo, Makoto
    Yamashita, Yugo
    CIRCULATION REPORTS, 2022, 4 (05) : 215 - 221